The number of Australian women referred to genetic clinics tripled immediately after Angelina Jolie’s announcement that she carried a faulty gene for breast and ovarian cancer.
Referrals across three states have remained at double the volume since May this year.
Women who have a mutation in the BRCA1 and BRCA2 genes are at an increased risk of developing breast and ovarian cancers.
Peter MacCallum Cancer Centre’s Mary-Anne Young said the greater awareness of genetic risk would save lives.
Read the full, original story here: Angelina Jolie revelation triples breast, ovarian cancer genetic testing
